RESOURCE LIBRARY

Back Bay Life Science Advisors provides strategic and investment banking guidance and execution to global biopharma and medtech companies of all stages and sectors. With unique integration of life science strategy and investment banking, Back Bay enables global companies and investors to make informed decisions regarding product development, commercialization, franchising, licensing, partnering, M&A, divestitures and more. 

In 2023, Back Bay, together with DNB Bank, announced the DNB//Back Bay Partnership for Healthcare. This Partnership provides a full range of strategic and financing capabilities for healthcare companies, including strategy, equity and debt capital markets, M&A and resources. Our combination of expertise spans more than 110 years and 1,000+ successful projects and transactions.

Our global healthcare team consists of more than 100 experienced investment and corporate bankers who work alongside seasoned healthcare strategic advisors.

We are a team with one mission: moving healthcare forward.